Andrea S. Blevins Primeau, PhD, MBA

Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.

Most Recent Articles by Andrea S. Blevins Primeau, PhD, MBA

First-line Immune Checkpoint Inhibition Cost-effective in Melanoma

First-line Immune Checkpoint Inhibition Cost-effective in Melanoma

By

First-line immune checkpoint inhibition is more cost-effective than chemotherapy for treatment-naïve, BRAF wild-type, stage IV melanoma.

2017 ASCO GU Symposium: Updates in Managing Small Renal Masses

2017 ASCO GU Symposium: Updates in Managing Small Renal Masses

By

At a general session at the 2017 ASCO GU Symposium, the latest advances in managing SRMs will be discussed.

Statins During Endocrine Therapy May Reduce Risk of Breast Cancer Recurrence

Statins During Endocrine Therapy May Reduce Risk of Breast Cancer Recurrence

By

CLM use during adjuvant endocrine therapy may reduce risk of recurrence in women with early-stage, HR-positive breast cancer.

<i>BRCA</i> Reversion Mutations Detected in Ovarian Tumor cfDNA

BRCA Reversion Mutations Detected in Ovarian Tumor cfDNA

By

Acquired reversion mutations in BRCA1/2 are detectable in circulating cell-free DNA (cfDNA) in women with high-grade serous ovarian cancer (HGSC).

Acquired <i>BTK</i> and <i>PLCG2</i> Mutations Linked to Future CLL Relapse

Acquired BTK and PLCG2 Mutations Linked to Future CLL Relapse

By

Acquired mutations in BTK or PLCG2 were detected in patients with chronic lymphocytic leukemia (CLL) prior to relapse.

More Articles by Andrea S. Blevins Primeau, PhD, MBA

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters